Literature DB >> 32813539

Blood pressure and albuminuria in a female mouse model of systemic lupus erythematosus: impact of long-term high salt consumption.

Elena L Dent1, Hanna J Broome2, Jennifer M Sasser3, Michael J Ryan1,4.   

Abstract

Hypertension and kidney involvement are common in patients with autoimmune disease. Sodium intake is linked to hypertension in both human and animal studies. Evidence suggests that dietary salt may be an important environmental factor that promotes autoimmune activity. Therefore, we hypothesized that a long-term high-salt diet would accelerate the progression of autoimmunity, hypertension, and albuminuria during systemic lupus erythematosus (SLE), an autoimmune disease that predominantly affects young women and has a high prevalence of hypertension and renal disease. To test this hypothesis, an established experimental model of SLE (female NZBWF1 mice) that develops hypertension and renal disease was used. SLE mice were fed a high-salt (4% NaCl) or normal (0.4% NaCl) diet for 24 wk beginning at 10 wk of age and ending at 34 wk of age, a time by which female NZBWF1 mice typically have hypertension and exhibit signs of renal disease. Plasma anti-dsDNA autoantibodies were measured as an indicator of active SLE disease, and urinary albumin was monitored longitudinally as a marker of renal disease. Arterial pressure was measured in conscious, freely moving mice at 34 wk of age. Urinary endothelin-1 (ET-1) excretion, renal endothelin A and B receptor protein expression, and renal mRNA expression of NOS1, NOS2, NOX2, MCP-1, TNF-α, serum- and glucocorticoid-regulated kinase 1, and interleukin-2 (IL-2) were assessed to determine the impact on gene products commonly altered by a high-salt diet. SLE mice fed a high-salt diet had increased circulating autoantibodies, but the high-salt diet did not significantly affect albuminuria or arterial pressure. Urinary ET-1 excretion was increased, whereas renal endothelin A receptor and IL-2 expression were decreased in response to a high-salt diet. These data suggest that a chronic high-salt diet may not accelerate cardiovascular and renal consequences commonly associated with SLE.

Entities:  

Keywords:  autoimmunity; endothelin; hypertension; interleukin-2; systemic lupus erythematosus

Mesh:

Substances:

Year:  2020        PMID: 32813539      PMCID: PMC7642904          DOI: 10.1152/ajpregu.00070.2020

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  54 in total

1.  Increased case fatality rates following a first acute cardiovascular event in patients with rheumatoid arthritis.

Authors:  S Van Doornum; C Brand; B King; V Sundararajan
Journal:  Arthritis Rheum       Date:  2006-07

2.  Prevalence of cardiovascular risk factors in patients with psoriasis.

Authors:  Andrea L Neimann; Daniel B Shin; Xingmei Wang; David J Margolis; Andrea B Troxel; Joel M Gelfand
Journal:  J Am Acad Dermatol       Date:  2006-09-25       Impact factor: 11.527

Review 3.  Role of dietary salt and potassium intake in cardiovascular health and disease: a review of the evidence.

Authors:  Kristal J Aaron; Paul W Sanders
Journal:  Mayo Clin Proc       Date:  2013-09       Impact factor: 7.616

4.  Oxidative stress promotes hypertension and albuminuria during the autoimmune disease systemic lupus erythematosus.

Authors:  Keisa W Mathis; Marcia Venegas-Pont; C Warren Masterson; Nicholas J Stewart; Katie L Wasson; Michael J Ryan
Journal:  Hypertension       Date:  2012-01-30       Impact factor: 10.190

5.  Sodium intake and multiple sclerosis activity and progression in BENEFIT.

Authors:  Kathryn C Fitzgerald; Kassandra L Munger; Hans-Peter Hartung; Mark S Freedman; Xavier Montalbán; Gilles Edan; Eva-Maria Wicklein; Ernst-Wilhelm Radue; Ludwig Kappos; Christoph Pohl; Alberto Ascherio
Journal:  Ann Neurol       Date:  2017-07       Impact factor: 10.422

Review 6.  Endothelin and endothelin receptors in the renal and cardiovascular systems.

Authors:  Nicolas Vignon-Zellweger; Susi Heiden; Takashi Miyauchi; Noriaki Emoto
Journal:  Life Sci       Date:  2012-03-28       Impact factor: 5.037

7.  Tumor necrosis factor-alpha antagonist etanercept decreases blood pressure and protects the kidney in a mouse model of systemic lupus erythematosus.

Authors:  Marcia Venegas-Pont; Michaele B Manigrasso; Samira C Grifoni; Babbette B LaMarca; Christine Maric; Lorraine C Racusen; Porter H Glover; Allison V Jones; Heather A Drummond; Michael J Ryan
Journal:  Hypertension       Date:  2010-08-09       Impact factor: 10.190

Review 8.  Systemic lupus erythematosus: emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease.

Authors:  D T Boumpas; H A Austin; B J Fessler; J E Balow; J H Klippel; M D Lockshin
Journal:  Ann Intern Med       Date:  1995-06-15       Impact factor: 25.391

Review 9.  Understanding the epidemiology and progression of systemic lupus erythematosus.

Authors:  Guillermo J Pons-Estel; Graciela S Alarcón; Lacie Scofield; Leslie Reinlib; Glinda S Cooper
Journal:  Semin Arthritis Rheum       Date:  2009-01-10       Impact factor: 5.532

10.  High salt promotes autoimmunity by TET2-induced DNA demethylation and driving the differentiation of Tfh cells.

Authors:  Haijing Wu; Xin Huang; Hong Qiu; Ming Zhao; Wei Liao; Shuguang Yuan; Yubing Xie; Yong Dai; Christopher Chang; Akihiko Yoshimura; Qianjin Lu
Journal:  Sci Rep       Date:  2016-06-21       Impact factor: 4.379

View more
  1 in total

1.  Dual Costimulatory and Coinhibitory Targeting with a Hybrid Fusion Protein as an Immunomodulatory Therapy in Lupus Nephritis Mice Models.

Authors:  Jordi Guiteras; Elena Crespo; Pere Fontova; Nuria Bolaños; Montse Gomà; Esther Castaño; Oriol Bestard; Josep M Grinyó; Joan Torras
Journal:  Int J Mol Sci       Date:  2022-07-29       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.